164 related articles for article (PubMed ID: 35317900)
1. The Use of Lipoprotein-Associated Phospholipase A2 in a Chinese Population to Predict Cardiovascular Events.
Xi H; Cheng GL; Hu FF; Li SN; Deng X; Zhou Y
Biomed Environ Sci; 2022 Mar; 35(3):206-214. PubMed ID: 35317900
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.
Elkind MS; Leon V; Moon YP; Paik MC; Sacco RL
Stroke; 2009 Oct; 40(10):3233-7. PubMed ID: 19644070
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of lipoprotein-associated phospholipase A
Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.
Chong Y; Ren Q; Li Y; Li C; Feng F; Zhou Y
Int Heart J; 2020 Jan; 61(1):109-114. PubMed ID: 31875617
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
8. Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.
Wang Y; Zhou B; Zhou P; Yao Y; Cui Q; Liu Y; Yang J; Wu S; Zhao X; Zhou Y
J Cell Mol Med; 2018 Apr; 22(4):2329-2336. PubMed ID: 29424477
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.
Wallentin L; Held C; Armstrong PW; Cannon CP; Davies RY; Granger CB; Hagström E; Harrington RA; Hochman JS; Koenig W; Krug-Gourley S; Mohler ER; Siegbahn A; Tarka E; Steg PG; Stewart RA; Weiss R; Östlund O; White HD;
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27329448
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients.
De Mauri A; Vidali M; Chiarinotti D; Bellomo G; Rolla R
J Nephrol; 2019 Apr; 32(2):283-288. PubMed ID: 30168082
[TBL] [Abstract][Full Text] [Related]
11. Correlation between plasma lipoprotein-associated phospholipase A2 levels and risk of ischaemic stroke recurrence by gender in the Chinese population.
Huang J; Lu K; Xie D; Dong S; Zhu F; Lu B; Liu A
Neurol Res; 2024 Jul; 46(7):679-689. PubMed ID: 38602308
[TBL] [Abstract][Full Text] [Related]
12. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
[TBL] [Abstract][Full Text] [Related]
13. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
14. Effects of Extended-Release Niacin on Quartile Lp-PLA
Lyubarova R; Albers JJ; Marcovina SM; Yao Y; McBride R; Topliceanu A; Anderson T; Fleg JL; Desvigne-Nickens P; Kashyap ML; McGovern ME; Boden WE
J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):534-541. PubMed ID: 31131629
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study.
Lin L; Teng J; Shi Y; Xie Q; Shen B; Xiang F; Cao X; Ding X; Xu X; Zhang Z
Lipids Health Dis; 2024 Jan; 23(1):15. PubMed ID: 38216940
[TBL] [Abstract][Full Text] [Related]
16. Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study.
White HD; Simes J; Stewart RA; Blankenberg S; Barnes EH; Marschner IC; Thompson P; West M; Zeller T; Colquhoun DM; Nestel P; Keech AC; Sullivan DR; Hunt D; Tonkin A;
J Am Heart Assoc; 2013 Oct; 2(5):e000360. PubMed ID: 24152981
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of Lipoprotein-Associated Phospholipase A
Yang L; Wang H; Zhang Y; Han T; Wang W
Clin Appl Thromb Hemost; 2018 Jul; 24(5):822-827. PubMed ID: 29121808
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial.
O'Donoghue M; Morrow DA; Sabatine MS; Murphy SA; McCabe CH; Cannon CP; Braunwald E
Circulation; 2006 Apr; 113(14):1745-52. PubMed ID: 16537575
[TBL] [Abstract][Full Text] [Related]
19. Lp-PLA2 evaluates the severity of carotid artery stenosis and predicts the occurrence of cerebrovascular events in high stroke-risk populations.
Zhang F; Guo J; Yang F; Zhou Y
J Clin Lab Anal; 2021 Mar; 35(3):e23691. PubMed ID: 33458873
[TBL] [Abstract][Full Text] [Related]
20. Higher Levels of Lipoprotein Associated Phospholipase A2 is associated with Increased Prevalence of Cognitive Impairment: the APAC Study.
Jiang R; Chen S; Shen Y; Wu J; Chen S; Wang A; Wu S; Zhao X
Sci Rep; 2016 Sep; 6():33073. PubMed ID: 27609335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
